American Society of Hirudotherapy

Comparative Transcriptomics of Three Hirudo Species

Salivary-cell RNA-seq of H. medicinalis, H. orientalis and H. verbana with proteomic validation, plus a draft H. medicinalis genome

Last Updated: November 1, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportGenomics & ProteomicsSalivary PharmacologyBabenko VV et al. · BMC Genomics, 2020

Summary

RNA-seq of laser-microdissected salivary cells and muscle from three Hirudo species (H. medicinalis, H. orientalis, H. verbana), with proteomic validation of the salivary cell secretion and a draft H. medicinalis genome. Differential expression analysis found 102, 174 and 72 salivary-cell transcripts in the three species respectively, grouped into 25 orthologous clusters shared by all three species (44 shared by at least two). Proteomics identified 189 (H. medicinalis), 86 (H. orientalis) and 344 (H. verbana) proteins in the secretion, with 39 orthologous clusters shared by all three species. Well-known anticoagulants such as hirudin, bdellins, eglins, saratins and destabilases were not differentially expressed between salivary cells and muscle.

Citation

Draft genome sequences of Hirudo medicinalis and salivary transcriptome of three closely related medicinal leeches

Babenko VV et al. · BMC Genomics, 2020

Added to ASH library: March 18, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.